Babcock & Wilcox stock offering tests rally after 50% weekly surge
Markets Daniel Marsh

Babcock & Wilcox stock offering tests rally after 50% weekly surge

Babcock & Wilcox closes $200M stock offering at $18.50 after shares surged 50% on Q1 revenue growth and AI data center demand. Investors watch for dilution impact Monday.

BW
McCormick Shares Test Key Support Ahead of Unilever Deal Vote
Markets Daniel Marsh

McCormick Shares Test Key Support Ahead of Unilever Deal Vote

McCormick shares slipped to $46.35 after touching a weekly low of $44.82, as the market awaits Monday's session to determine if the Unilever deal pressure intensifies.

MKC
Berkshire Hathaway Faces Key Monday Test After Abel's $24 Billion Portfolio Overhaul
Markets Daniel Marsh

Berkshire Hathaway Faces Key Monday Test After Abel's $24 Billion Portfolio Overhaul

Berkshire Hathaway faces a key test Monday after Greg Abel's first major portfolio shakeup, adding Delta Air Lines and Alphabet while exiting Amazon, Visa, and Mastercard.

BRK.B DAL M GOOGL AMZN UNH V MA CVX
Hyliion Stock Surges 90% on Q1 Earnings, KARNO Progress
Earnings James Calloway

Hyliion Stock Surges 90% on Q1 Earnings, KARNO Progress

Hyliion shares surged nearly 90% this week after Q1 revenue of $2.8 million and progress on its KARNO power module. The stock closed at $4.67 on Friday.

HYLN BE FCEL
NuScale Power Faces Critical Monday After Steep Weekly Decline
Markets Daniel Marsh

NuScale Power Faces Critical Monday After Steep Weekly Decline

NuScale Power shares dropped 6.88% Friday to $11.23, capping a 10.5% weekly loss. Citi cut its target to $7 (Sell), Northland to $19 (Outperform). Q1 revenue fell sharply; net loss widened.

SMR
SpaceX IPO Buzz Fuels Tema NASA ETF Weekly Rally
IPO Michael Okonkwo

SpaceX IPO Buzz Fuels Tema NASA ETF Weekly Rally

Tema NASA ETF rose 7.5% for the week despite a 3.9% Friday drop, as SpaceX IPO buzz and a potential Nasdaq listing drive investor interest.

RKLB
Natera Shares Slide Despite FDA Approval for Bladder Cancer Test
Markets Daniel Marsh

Natera Shares Slide Despite FDA Approval for Bladder Cancer Test

Natera shares dropped 5.36% Friday, even after the FDA approved its Signatera CDx test for use with Genentech's Tecentriq in muscle-invasive bladder cancer. The stock closed at $186.36.

NTRA
Devon Energy Surges 4.76% After Coterra Merger Close, Eyes $50 Resistance
Markets Daniel Marsh

Devon Energy Surges 4.76% After Coterra Merger Close, Eyes $50 Resistance

Devon Energy shares surged 4.76% to $49.49 Friday, outperforming peers after closing its Coterra merger and unveiling an $8 billion buyback. Oil prices climbed above $105, supporting the stock.

DVN USO XLE EOG FANG
Starbucks Faces Key Resistance After Announcing $400M Restructuring
Markets Daniel Marsh

Starbucks Faces Key Resistance After Announcing $400M Restructuring

Starbucks shares hover near 52-week highs after the coffee giant revealed a $400 million restructuring plan involving 300 corporate job cuts and regional office closures, part of CEO Brian Niccol's turnaround strategy.

SBUX
NextEra Energy Stock Drops on $400B Dominion Merger Report
Markets Daniel Marsh

NextEra Energy Stock Drops on $400B Dominion Merger Report

NextEra Energy shares dropped 2.42% to $93.36 Friday following a report of potential merger talks with Dominion Energy that could value the combined entity at $400 billion.

NEE D
Atlassian Stock Rebounds on Friday, AI Monetization in Focus Next Week
Technology Sarah Chen

Atlassian Stock Rebounds on Friday, AI Monetization in Focus Next Week

Atlassian shares surged 8% on Friday, recovering from weekly losses, as Truist Securities reiterated a Buy rating with a $100 target, citing AI monetization as a key focus after the Team 26 event.

TEAM
SolarEdge Surges Nearly 50% in a Week; Monday Session Could Define Trend
Markets Daniel Marsh

SolarEdge Surges Nearly 50% in a Week; Monday Session Could Define Trend

SolarEdge shares surged nearly 50% in a week, closing Friday at $61.76. The rally was fueled by Q1 revenue, strong Q2 guidance, and tax-credit deadline demand. Monday's session will test the breakout.

SEDG ENPH FSLR